IN8bio, Inc. (INAB)
NASDAQ: INAB · Real-Time Price · USD
0.1713
-0.0248 (-12.65%)
Mar 31, 2025, 2:35 PM EDT - Market open

IN8bio Statistics

Total Valuation

IN8bio has a market cap or net worth of $13.92 million. The enterprise value is $7.85 million.

Market Cap 13.92M
Enterprise Value 7.85M

Important Dates

The last earnings date was Thursday, March 13, 2025, after market close.

Earnings Date Mar 13, 2025
Ex-Dividend Date n/a

Share Statistics

IN8bio has 81.26 million shares outstanding. The number of shares has increased by 79.30% in one year.

Current Share Class 81.26M
Shares Outstanding 81.26M
Shares Change (YoY) +79.30%
Shares Change (QoQ) +62.96%
Owned by Insiders (%) 7.49%
Owned by Institutions (%) 13.77%
Float 53.31M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 0.98
P/TBV Ratio 0.96
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 4.08, with a Debt / Equity ratio of 0.35.

Current Ratio 4.08
Quick Ratio 3.61
Debt / Equity 0.35
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -154.44% and return on invested capital (ROIC) is -74.99%.

Return on Equity (ROE) -154.44%
Return on Assets (ROA) -67.70%
Return on Invested Capital (ROIC) -74.99%
Return on Capital Employed (ROCE) -165.72%
Revenue Per Employee n/a
Profits Per Employee -$1.69M
Employee Count 18
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -83.79% in the last 52 weeks. The beta is 0.02, so IN8bio's price volatility has been lower than the market average.

Beta (5Y) 0.02
52-Week Price Change -83.79%
50-Day Moving Average 0.26
200-Day Moving Average 0.44
Relative Strength Index (RSI) 30.32
Average Volume (20 Days) 1,251,564

Short Selling Information

The latest short interest is 1.67 million, so 2.05% of the outstanding shares have been sold short.

Short Interest 1.67M
Short Previous Month 800,501
Short % of Shares Out 2.05%
Short % of Float 3.13%
Short Ratio (days to cover) 0.67

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -29.60M
Pretax Income -31.96M
Net Income -30.44M
EBITDA -27.76M
EBIT -29.60M
Earnings Per Share (EPS) -$0.57
Full Income Statement

Balance Sheet

The company has $11.12 million in cash and $5.03 million in debt, giving a net cash position of $6.09 million or $0.07 per share.

Cash & Cash Equivalents 11.12M
Total Debt 5.03M
Net Cash 6.09M
Net Cash Per Share $0.07
Equity (Book Value) 14.48M
Book Value Per Share 0.20
Working Capital 9.50M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$24.15 million and capital expenditures -$187,000, giving a free cash flow of -$24.34 million.

Operating Cash Flow -24.15M
Capital Expenditures -187,000
Free Cash Flow -24.34M
FCF Per Share -$0.30
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

IN8bio does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -79.30%
Shareholder Yield -79.30%
Earnings Yield -218.41%
FCF Yield -174.63%

Analyst Forecast

The average price target for IN8bio is $3.60, which is 2,001.58% higher than the current price. The consensus rating is "Strong Buy".

Price Target $3.60
Price Target Difference 2,001.58%
Analyst Consensus Strong Buy
Analyst Count 2
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 1